Reproductive and developmental safety of nirmatrelvir (PF-07321332), an oral SARS-CoV-2 Mpro inhibitor in animal models
Natasha R. Catlin, Christopher Bowman, Sarah N. Campion, Jenny Cheung, William S. Nowland, Jean G. Sathish, Christine M. Stethem, Lawrence W. Updyke, Gregg D. Cappon
Topics & Concepts
ToxicityAdverse effectPopulationBiologyPharmacologyDevelopmental toxicityMedicinePhysiologyPregnancyInternal medicineFetusGeneticsEnvironmental healthCOVID-19 Impact on ReproductionPregnancy and Medication ImpactPregnancy and preeclampsia studies